Versatility.Reusability.Connectivity
Redefining possibilities with
VersatilityReusability
Connectivity
Adaptable electromechanical autoinjector technology for your needs
Versatility
Adapt to pharma needs for
future innovations
Reusability
patient training
Connectivity
pharma and patients
Versatile solution
One interface for both pre-filled syringes and cartridges
Elexy™ provides best-in-class flexibility for a wide range of injection profiles, including varying volumes, viscosities, injection times, and primary containers, all while maintaining assured performance. Elexy’s power unit is compatible with drug cassettes containing a pre-filled syringe (1.0 mL and 2.25 mL) or a cartridge (3.0 mL and 5.0 mL).
Ideal for clinical trials
Clinical trials demand various injection scenarios to collect comprehensive data. Researchers need to test different injection parameters to ensure the drug’s effectiveness and safety across diverse patient groups and conditions. Elexy meets these needs through its adaptability to cover a wide range of injection profiles.
Ideal for future drug innovations
With innovative drug therapies under rapid development in today’s self-injection space, the need for a versatile solution that provides market readiness becomes even more paramount. Device companies must be able to quickly adapt to different requirements and streamline the development processes to stay competitive. Elexy’s adaptability optimizes time to market, allowing pharma and biotech companies to respond swiftly to emerging therapeutic needs.
Reusable unit
Elexy™ is designed to align with your sustainability goals
Elexy, with its reusable power unit, is designed to reduce the consumption of natural resources, waste, and carbon footprint for chronic disease treatments requiring multiple injections.
Optimal for carbon footprint reduction
Elexy reduces carbon footprint by leveraging SHL’s global sites and in-house manufacturing capabilities. By optimizing transportation and logistics, we not only enhance operational efficiency but also cut down on emissions, supporting pharma and biotech companies to operate in alignment with their sustainability principles.
Optimal for patient training
Onboarding patients with at-home injections often requires a fresh device for each training session. A reusable power unit enables Elexy to be used for training purposes, with the same power unit utilized across multiple sessions. Elexy’s patient-centric design, requiring just two steps—inserting and removing the drug cassette—also ensures a smooth user experience.
Integrated connectivity
Enhancing experience for pharma and patients
Elexy™ provides the broadest range of connectivity profile with cellular and Bluetooth® options to enable the collection of comprehensive injection data.
For pharma and biotech companies
For pharma and biotech companies, connected autoinjectors often serve the crucial purpose of gathering timely and accurate insights during clinical trials. Elexy is an ideal solution for this scenario, offering greater flexibility to gather data to support market propositions.
With an integrated connectivity, Elexy provides a secure collection of comprehensive data, including injection time-stamp, duration, and injection behaviors such as early lift. Elexy also facilitates easy patient onboarding with training devices, ensuring a smooth user experience.
For patients
With Elexy’s cellular connectivity, the injection process remains simple, safeguarding ease of use with no additional pairing steps required. Moreover, designed with patient-centricity in mind, Elexy’s ergonomic design, combined with simple push-to-activate operation and multiple feedback mechanisms, encourage patients to stay engaged in their treatment regimen.
Injection feedback you can’t miss
Visual
Light
Tactile
Audio
Patient-centric development
Elexy™’s technology is supported by SHL Medical’s extensive experience in industrial design, incorporating usability engineering at every step of the development process. Over the years, we have been conducting extensive studies including qualitative research, preference, and user studies, involving a wide range of patient groups across various disease areas* and age groups, to ensure that Elexy meets the needs of a diverse patient base.
*autoimmune disease, metabolic disease, inflammatory disease, and respiratory disease (the list is non-exhaustive)
Excited about Elexy™?
Talk to our representatives for a personal demo!
The Bluetooth® word marks and logos are registered trademarks of Bluetooth SIG, Inc. This website includes forward-looking information that may be subject to change. Concept under development.